Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor.

Closed
75N98026Q01083ENAMINEYSINCFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424690
New
International
WS593(922)5404 - 10(00)044(688) - Adquisición de medios filtrantes para neutralizar gases de bajo peso molecular y para control de sulfuro de hidrogeno
Solicitation # 1000044688
Triple A S.A. E.S.P. has issued solicitation 1000044688 as an abridged invitation to bid for the acquisition of filtering media used to neutralize low molecular weight gases and control hydrogen sulfide. The scope of work requires the supply of 30 units of ODORCARB ULTRA and 16 units of ODORMIX SP, both in 40 lb filtering beds. These materials must adhere to strict technical specifications regarding bulk density, moisture, crush strength, and pellet diameter. Delivery is to be made to the Sede de Acueducto within eight weeks following the approval of required insurance policies. The contract will be awarded based on an economic qualification criterion, provided that the bidder meets all legal, technical, and economic requirements. In the event of a tie, priority is given to the bidder with the shortest delivery time. Awarded contractors must provide a stability policy for 20% of the contract value and an extracontractual civil liability policy for 30% of the value. All proposals and administrative documentation, including the RUT and Chamber of Commerce certificates, must be submitted via the SAP Ariba platform. Payment terms vary by category, with general supply typically processed after the presentation of invoices.
Triple A S.A. E.S.P.

POSTED

about 11 hours ago

DEADLINE

in 8 days

AI Contract Overview

Show more

The National Institutes of Health (NIH) is seeking chemical reagent assay development and laboratory testing services to support the Section on Medicinal Chemistry in developing new molecular entities for metabolic and alcohol-associated diseases. The primary objective is to assess the translational potential of these compounds through a series of derisking assays. This includes grouped ADME assays such as Caco-2 Permeability to predict oral absorption, CACO and MDCKR assays for brain penetrance, hERG assays for cardiac toxicity, and plasma stability and binding tests to evaluate behavior in bodily fluids. The highest performing compounds will then undergo in vivo pharmacokinetic studies in C57BL6 mice to determine oral availability. This procurement is currently a pre-solicitation notice of intent, conducted under FAR Part 13 Simplified Acquisition Procedures, with a total value not exceeding the simplified acquisition threshold of 350,000 dollars. The government is evaluating whether to proceed with a non-competitive award to Enamine US Inc. or to conduct a competitive procurement. Interested parties must submit a technical proposal, cost-price proposal, period of performance, Unique Entity ID, Taxpayer Identification Number, and business size certification to the NIH Office of Logistics and Operations in Bethesda, Maryland.

General Info

NIH seeks vendor for chemical reagent assay development and laboratory testing services.

NAICS

424690 - Other Chemical and Allied Products Merchant Wholesalers

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

1

Notice of Intent - VISHNU ENAMINE NIAAA 08396

DOCX, Low priorityspecial-notice
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts
Vishnuvajjala Hanumanth Rao

Full Description

Show more

Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. 


  1. The Section on Medicinal Chemistry (SMC) develops new molecular entities with implications in improving health and treatment for various metabolic and alcohol associated diseases. To assess the translational potential of novel molecular entities, which would allow us to make decisions to proceed with the compounds for further development we utilize multiple derisking assays. These assays comprise of both cell-based (in vitro) testing and then eventually in mice to assess pharmacokinetic parameters to see if the drug is orally available.

Request to procure Chemical Reagent (Assay) Development & Laboratory Testing Service SMC to produce grouped ADME assays and perform a Pharmacokinetic study in C57BL6 mice. By including the Caco-2 Permeability Assay in our ADME evaluation it'll accurately predict the oral absorption potential of our compounds. This well-established in vitro model closely mimics the human intestinal epithelium, providing critical insights into a compound’s passive diffusion, active transport, and efflux processes, such as those mediated by P-glycoprotein (P-gp). The data generated from this assay are vital for informing structure-activity relationship (SAR) optimization, improving compound permeability, and reducing transporter-related liabilities that could hinder bioavailability. CACO and MDCKR assays allow to know the brain penetrance of the compounds. hERG assays allow to know if the compounds will show cardiac toxicity. The plasma stability and binding show how the compounds behave in bodily fluids. Finally, the best compounds then undergo testing in mice to know if they can be given orally and thus have translational potential in human testing. These assays are integral to the work of section on medicinal chemistry at NIAAA as these enable to progress compounds for further development as therapeutics in metabolic and alcohol use disorders.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541614
New
Federal
R--RADx Coordination Center Notice of Intent
Solicitation # 75N98026R00176
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has issued a Notice of Intent under solicitation 75N98026R00176 to award a non-competitive modification to IDIQ Contract No. 75N92022D00014. This modification intends to increase the contract ceiling for the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT) to support the Rapid Acceleration of Diagnostics (RADx-Tech) initiative. The initiative operates as an innovation funnel to accelerate the development, commercialization, and implementation of health technologies through a collaborative network consisting of a Coordination Center for operational oversight and workflows, a Commercialization Center for subject matter expert selection, and a Validation Center for technical and clinical verification. The government anticipates issuing the modification around December 2026. While this is a non-competitive intent, interested parties may submit capability statements via email to the contracting officer, Melanie Suarez, or contract specialist, Noelle Decenzo, by November 2, 2026. Submissions must reference the notice number and include details regarding employee count, professional qualifications of technical personnel, available facilities and equipment, and an outline of similar previous research projects. All responding parties must maintain an active registration in the System for Award Management (SAM).
Process, Physical Distribution, and Logistics Consulting Services

POSTED

5 days ago

DEADLINE

in 13 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS